Doctor profile · Federal record
Dr. Rachel Abramczyk, DO
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Parkesburg, PA
- NPI 1609360791
- Accepts Medicare
- MIPS 95.8 / 100 · 2023
- 8 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
950 S Octorara Trl
Parkesburg, PA 193652100
(717) 544-3059
Credentials & registration
- NPI registered
- June 2018 — 8 yrs on file
- Profile last updated
- January 9, 2026
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- Pennsylvania #OS022862
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609360791. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
352
Distinct HCPCS
6
Medicare allowed
$49,627
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 163 | 133 | $185 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 60 | 32 | $81 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 53 | 52 | $133 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 39 | 29 | $35 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 25 | 25 | $134 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 12 | 12 | $228 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 58. This provider delivers 6.1× the peer median.Open Payments
Industry payments received
All-time total
$2,124
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk Inc | 19 | $374.85 | |
| Lilly USA, LLC | 12 | $289.45 | |
| Abbott Laboratories | 12 | $257.80 | |
| Amgen Inc. | 7 | $165.88 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $105.72 | |
| Corcept Therapeutics | 3 | $87.92 | |
| ABBVIE INC. | 4 | $80.89 | |
| Kyowa Kirin, Inc. | 3 | $80.06 | |
| Medtronic, Inc. | 3 | $79.72 | |
| IBSA Pharma Inc. | 3 | $72.18 | |
| Tandem Diabetes Care, Inc. | 2 | $66.67 | |
| SANOFI-AVENTIS U.S. LLC | 3 | $64.24 | |
| Dexcom, Inc. | 2 | $53.69 | |
| Insulet Corporation | 2 | $48.48 | |
| Amphastar Pharmaceuticals, Inc. | 3 | $47.01 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
849
Patients
347
Total drug cost
$457,305
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trulicity (Dulaglutide) | Brand | 111 | 29 | $113,622 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 110 | 38 | $46,148 |
| Levothyroxine Sodium | Generic | 103 | 45 | $1,621 |
| Jardiance (Empagliflozin) | Brand | 94 | 35 | $97,321 |
| Ozempic (Semaglutide) | Brand | 67 | 21 | $79,402 |
| Metformin Hcl | Generic | 58 | 31 | $781 |
| Mounjaro (Tirzepatide) | Brand | 58 | 26 | $76,599 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 46 | 32 | $1,022 |
| Atorvastatin Calcium | Generic | 32 | 15 | $874 |
| Alendronate Sodium | Generic | 31 | 0 | $393 |
Hospital affiliations
Frequently asked questions
What is Dr. Rachel Abramczyk's medical specialty?
Dr. Rachel Abramczyk practices Endocrinology, Diabetes & Metabolism Physician in Parkesburg, PA.
Where does Dr. Rachel Abramczyk practice?
Dr. Rachel Abramczyk practices at 950 S Octorara Trl, Parkesburg, PA 193652100. Office phone: 7175443059.
What is Dr. Rachel Abramczyk's NPI?
Dr. Rachel Abramczyk's National Provider Identifier (NPI) is 1609360791, issued by NPPES.
Does Dr. Rachel Abramczyk accept Medicare assignment?
Yes. Dr. Rachel Abramczyk accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rachel Abramczyk commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.